Beijing Savant Biotechnology Co.,ltd

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Beijing Savant Biotechnology Co.,ltd - overview

Established

2007

Location

Beijing, -, China

Primary Industry

Biotechnology

About

Based in Beijing, China and established in 2007, Beijing Savant Biotechnology Co. ,ltd is a chemiluminescent immunoreagents developer that provides in vitro diagnosis products. It is a National High Tech Enterprise. In November 2015, the company raised series A funding from new investors Shanghai China Healthcare Venture Management and Shenzhen Tianyi Investment.


In June 2018, Beijing Savant Biotechnology Co. ,ltd closed a series D funding from new investor Zhuhai Jingxiang Capital Management. Beijing Savant Biotechnology Co. ,ltd focuses on quantitative immunoassays and is engaged in the research, development, production and sales of in vitro diagnostic reagents and instruments.


HuaKeTai has two major product lines which are chemiluminescence and POCT, with more than 260 industrial products. The products can be used in bone metabolism testing, liver fibrosis testing, diabetes testing, cardiac markers, tumour markers, and cytokine testing. The company also developed Magnetic Particle Fully Automatic Chemiluminescence Analyzer. The company generates revenue by producing tumour marker diagnostic reagents.


Current Investors

Shanghai China Healthcare Venture Management, Tianyi Investment, Hidea Investment

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment, Medical Supplies, Diagnostic Equipment

Website

www.huaketai.com

Verticals

Manufacturing

Company Stage

Series D

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.